For instance, Lixisenatide was evaluated for safety, efficacy, and adverse events in a randomized, double-blind, placebo-controlled, parallel-group, 13-week study of 542 patients with Type 2 diabetes inadequately controlled on metformin (1000 mg/day) treated with subcutaneous lixisenatide doses of 5, 10, 20, or 30 g once daily or twice daily or placebo
Building a Consistent Routine Consistency is far more important than the specific minute you take your supplement
Heres how much GLP-1 rises naturally in our bloodstream in the two hours after we eat a meal: up to maybe 20 or 30 pico moles
At the highest dose, roughly 10.5% average body-weight reduction at 26 weeks, about 11.8% at 36 weeks, vs ~0.30.6% on placebo
It hits three receptors simultaneously: GLP-1, GIP, and glucagon
Sharma RA, McLelland HR, Hill KA, et al